Patron Exim Ltd
Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.[1]
- Market Cap ₹ 13.9 Cr.
- Current Price ₹ 6.00
- High / Low ₹ 9.47 / 4.80
- Stock P/E 199
- Book Value ₹ 16.9
- Dividend Yield 0.00 %
- ROCE 0.28 %
- ROE 0.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.35 times its book value
- Debtor days have improved from 349 to 91.6 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.12% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Trading - Chemicals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
3.88 | 12.95 | 6.58 | 24.36 | |
3.41 | 16.92 | 9.33 | 24.57 | |
Operating Profit | 0.47 | -3.97 | -2.75 | -0.21 |
OPM % | 12.11% | -30.66% | -41.79% | -0.86% |
1.14 | 5.93 | 3.65 | 0.32 | |
Interest | 0.19 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.01 | 0.00 | 0.00 |
Profit before tax | 1.41 | 1.95 | 0.90 | 0.11 |
Tax % | 30.50% | 29.23% | 25.56% | 36.36% |
0.99 | 1.38 | 0.67 | 0.07 | |
EPS in Rs | 0.60 | 0.29 | 0.03 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 84% |
TTM: | 270% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -59% |
TTM: | -90% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 5.34 | 23.18 | 23.18 | 23.18 |
Reserves | 0.00 | 15.29 | 15.96 | 16.03 |
0.00 | 0.03 | 0.26 | 0.23 | |
5.62 | -0.02 | 5.93 | 4.81 | |
Total Liabilities | 10.96 | 38.48 | 45.33 | 44.25 |
0.01 | 0.01 | 0.01 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 8.67 | 8.67 | 8.76 |
10.95 | 29.80 | 36.65 | 35.48 | |
Total Assets | 10.96 | 38.48 | 45.33 | 44.25 |
Cash Flows
Figures in Rs. Crores
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
0.76 | -22.81 | -0.26 | -0.01 | |
0.00 | -8.68 | 0.00 | 0.00 | |
-0.76 | 31.78 | 0.23 | -0.03 | |
Net Cash Flow | 0.00 | 0.29 | -0.04 | -0.04 |
Ratios
Figures in Rs. Crores
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 710.24 | 393.75 | 561.92 | 91.55 |
Inventory Days | 336.84 | 89.82 | 308.75 | 42.61 |
Days Payable | 537.21 | -23.95 | 625.34 | 61.07 |
Cash Conversion Cycle | 509.87 | 507.52 | 245.33 | 73.09 |
Working Capital Days | 500.46 | 831.19 | 1,674.67 | 584.06 |
ROCE % | 8.90% | 2.31% | 0.28% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
16 Jul - Certificate confirming securities dematerialization compliance for quarter ended June 30, 2025.
-
Statement Of Deviation Or Variation Under Regulation 32(1) Of The SEBI (LODR) Regulations, 2015 Read With Applicable SEBI Circular
23 May - No deviation in utilization of Rs.16.68 Cr IPO funds as per prospectus till Mar 31, 2025.
-
Board Meeting Outcome for Audited Financial Results For The Year Ended March 31, 2025
23 May - Audited FY25 results approved; auditor notes tax dues, related party loans, governance non-compliance, and litigation risks.
- Audited Financial Results For The Year Ended March 31, 2025 23 May
Business Overview:[1]
PEL used to do trading of timber, cement sheets and other ancillary business, and also in surgical & non-surgical articles. Currently, company is an ISO 9001:2015, ISO 45001:2018, WHO-GMP, etc. certified trader and distributor of wide range of pharmaceutical raw material like Active Pharmaceutical Ingredients, Industrial, excipient, and solvents